[Do phosphodiesterase type 5 inhibitors generics enhance discontinuation due to price with patients suffering from erectile dysfunction?] / Les génériques d'inhibiteur de la 5 phosphodiestérase améliorent-ils l'observance au traitement en raison d'un coût moindre ?
Prog Urol
; 29(6): 326-331, 2019.
Article
in Fr
| MEDLINE
| ID: mdl-31151915
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Drugs, Generic
/
Commerce
/
Medication Adherence
/
Phosphodiesterase 5 Inhibitors
/
Erectile Dysfunction
Type of study:
Clinical_trials
/
Health_economic_evaluation
/
Observational_studies
/
Prevalence_studies
/
Risk_factors_studies
Limits:
Humans
/
Male
/
Middle aged
Language:
Fr
Journal:
Prog Urol
Journal subject:
UROLOGIA
Year:
2019
Document type:
Article
Country of publication:
France